Header Logo


Sonal Singh to Pancreatitis

This is a "connection" page, showing publications Sonal Singh has written about Pancreatitis.
Connection Strength

  1. Singh S. Glucagon-like peptide 1-based drugs and pancreatic safety--reply. JAMA Intern Med. 2013 Oct 28; 173(19):1843-4.
    View in: PubMed
    Score: 0.460
  2. Singh S, Chang HY, Richards TM, Weiner JP, Clark JM, Segal JB. Glucagonlike peptide 1-based therapies and risk of hospitalization for acute pancreatitis in type 2 diabetes mellitus: a population-based matched case-control study. JAMA Intern Med. 2013 Apr 08; 173(7):534-9.
    View in: PubMed
    Score: 0.443
  3. Singh S. Angiotensin-converting enzyme (ACE) inhibitor-induced acute pancreatitis: in search of the evidence. South Med J. 2006 Dec; 99(12):1327-8.
    View in: PubMed
    Score: 0.285
  4. Singh S, Loke YK. Statins and pancreatitis: a systematic review of observational studies and spontaneous case reports. Drug Saf. 2006; 29(12):1123-32.
    View in: PubMed
    Score: 0.268
  5. Singh S. Drug induced pancreatitis might be a class effect of statin drugs. JOP. 2005 Jul 08; 6(4):380; author reply 380-1.
    View in: PubMed
    Score: 0.259
  6. Singh S, Nautiyal A, Dolan JG. Recurrent acute pancreatitis possibly induced by atorvastatin and rosuvastatin. Is statin induced pancreatitis a class effect? JOP. 2004 Nov 10; 5(6):502-4.
    View in: PubMed
    Score: 0.247
  7. Chang HY, Hsieh CF, Singh S, Tang W, Chiang YT, Huang WF. Anti-diabetic therapies and the risk of acute pancreatitis: a nationwide retrospective cohort study from Taiwan. Pharmacoepidemiol Drug Saf. 2015 Jun; 24(6):567-75.
    View in: PubMed
    Score: 0.127
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.